cagrilintide tirzepatide combination study (10mg vials) cagrilintide clinical trials Once-weekly for

Peripheral Artery Disease (PAD): High cholesterol can also affect the arteries in your limbs, particularly your legs

Mounjaro (tirzepatide) is a self-injectable treatment used for weight loss and type 2 diabetes, helping control blood sugar and reduce appetite

With both drugs, gastrointestinal problems were the most common and it was tolerable for most patients

Weight loss medications can be powerful tools, but they are not magic

We understand that navigating health decisions, including considerations like blood donation eligibility, is part of a broader commitment to personal well-being

Lifestyle modifications form the cornerstone of management: Glycaemic control : Maintaining HbA1c within your individualised target range reduces microvascular and macrovascular complications